NCT01336218View on ClinicalTrials.gov

Effects of Administration of Fostamatinib on Blood Concentrations of Rifampicin in Healthy Subjects.

PHASE1CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions

Rheumatoid ArthritisHealthy Volunteers

Interventions

DRUG

fostamatinib

oral tablets, 150mg (3 X 50mg) single dose per period

DRUG

rifampicin

oral tablets, 600mg (2 X 300mg) 8 doses over 8 days

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY